Back to search
CNS Embryonal Tumor, Not Otherwise Specified
Clinical trial pipeline · Data from ClinicalTrials.gov
See which CNS Embryonal Tumor, Not Otherwise Specified trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which CNS Embryonal Tumor, Not Otherwise Specified trials you may qualify forThis is an open-label phase 1 safety and feasibility study that will employ multi-tumor antigen specific cytotoxic T lymphocytes (TSA-T) directed against proteo…
This is a multi-center, multinational phase 2 trial that aims to explore the use of molecular and clinical risk-directed therapy in treatment of children 0-4.99…
This is an open-label, multi-center, Phase 1/2 study of the brain-penetrant MEK inhibitor, mirdametinib (PD-0325901), in patients with pediatric low-grade gliom…
This phase I trial studies the side effects and best dose of APX005M in treating younger patients with primary malignant central nervous system tumor that is gr…
The Register is based on the study HIT 2000 that recruited patients until 31.12.2011. All german patients with intracranial medulloblastoma, CNS-PNET, ependymom…
This research study involves an investigational product: Ad-RTS-hIL-12 given with veledimex for production of human IL-12. IL-12 is a protein that can improve t…